Applied Dna Sciences Inc Net debt/EBITDA
What is the Net debt/EBITDA of Applied Dna Sciences Inc?
The Net debt/EBITDA of Applied Dna Sciences Inc is 3.29
What is the definition of Net debt/EBITDA?
The net debt to earnings before interest, taxes, depreciation, and amortization (Net debt/EBITDA) ratio measures financial leverage and the company’s ability to pay off its debt. It shows how long it would take the company to pay off all its debt with operations at the current level.
The net debt to EBITDA ratio is calculated as Net debt divided by EBITDA. It is similar to the debt to EBITDA ratio, but cash and cash equivalents are subtracted in net debt.
Net debt = short-term debt + long-term debt - cash and cash equivalents
EBITDA = net income + interest expense + taxes + depreciation + amortization
Lower debt debt to EBITDA ratio indicates the company is not heavily indebted and should be able to repay its obligations. Alternatively, higher ratio indicated the company is excessively indebted. The ratio varies between industries as different industries have different capital requirements. Usually, the ratio should be compared to a benchmark or an industry average to determine the company’s credit risk. Generally, a net debt to EBITDA ratio above 4 or 5 is considered high.
Net debt/EBITDA of companies in the Industrials sector on NASDAQ compared to Applied Dna Sciences Inc
What does Applied Dna Sciences Inc do?
we keep life real and safe by providing botanical-dna based security and authentication solutions and services that protect assets, products, brands, supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion.
Companies with net debt/ebitda similar to Applied Dna Sciences Inc
- MTU Aero Engines AG has Net debt/EBITDA of 3.28
- Evotec SE has Net debt/EBITDA of 3.28
- Rubius Therapeutics Inc has Net debt/EBITDA of 3.28
- Phreesia Inc has Net debt/EBITDA of 3.29
- S.A.S. Dragon has Net debt/EBITDA of 3.29
- Esco Technologies has Net debt/EBITDA of 3.29
- Applied Dna Sciences Inc has Net debt/EBITDA of 3.29
- Pelatro Plc has Net debt/EBITDA of 3.30
- Intuit has Net debt/EBITDA of 3.30
- Sunway International has Net debt/EBITDA of 3.30
- Exicure has Net debt/EBITDA of 3.30
- Exicure has Net debt/EBITDA of 3.30
- Exicure has Net debt/EBITDA of 3.30